… ProQR Announces Third Quarter 2021 Operating and Financial … with Lilly highlights significant potential of ProQR’s Axiomer ® RNA base-editing platform and strengthens … Officer,” said Daniel A. de Boer, Founder and CEO of ProQR. “Theresa is a seasoned leader with deep rare disease …
… ProQR Announces Third Quarter 2024 Operating and Financial … & CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company … approximately $82.1 million. Research and development (R&D) costs were €9.4 million for the quarter ended September …
… ProQR Announces Results for the First Quarter of 2018 Key … RNA editing expert Dr. Peter A. Beal was appointed to ProQR’s scientific advisory board. LEIDEN, the Netherlands, … said Daniel A. de Boer, Chief Executive Officer of ProQR. “Recently, we entered our first corporate partnership …
… ProQR Announces First Quarter 2021 Operating and Financial … & CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … for the same period last year. Research and development (R&D) costs were €8.9 million for the quarter ended March 31, …
… ProQR to Present at Two Investor Conferences in September … at 9:10am ET, Daniel de Boer, Chief Executive Officer of ProQR, will present at the Cantor Fitzgerald Global … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and …
… ProQR Announces Second Quarter 2022 Operating and Financial … CNS therapeutic areas, which have strong alignment with ProQR’s oligonucleotide delivery approaches. The Company will … scheme by the EMA. About Usher s yndrome t ype 2 a and r etinitis p igmentosa Usher syndrome is the leading cause of …
… ProQR to Webcast Virtual Analyst Event on November 18 LEIDEN, … & CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … webcast link or from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under “ Events ”. Archived …
… ProQR to Present at Upcoming Scientific and Industry … & CAMBRIDGE, Mass., March 07, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through …
… ProQR Announces Second Quarter 2021 Operating and Financial … & CAMBRIDGE, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … eye disease,” said Daniel A. de Boer, Founder and CEO of ProQR. “We completed enrollment in the pivotal trial of …
… ProQR Announces Upcoming Investor Conferences in April and … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … will be accessible from the “Investors & Media” section of ProQR’s website under “ Events ”. Archived webcasts will be …